Evidence map›Paper›PMID 25343607›Full record

ArticleNature chemistry2014

Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides.

Shiyu Chen, Ranganath Gopalakrishnan, Tifany Schaer, Fabrice Marger, Ruud Hovius, Daniel Bertrand, Florence Pojer, Christian Heinis

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Peptidic Sulfhydryl for Interfacing Nanocrystals and Subsequent Sensing of SARS-CoV-2 Protease.Chemistry of materials : a publication of the American Chemical Society · 2022
    Article
  7. Article
  8. Biosynthetic Strategies for Macrocyclic Peptides.Molecules (Basel, Switzerland) · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Therapeutics targeting the fibrinolytic system.Experimental & molecular medicine · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Bicyclic Peptides as Next-Generation Therapeutics.Chemistry (Weinheim an der Bergstrasse, Germany) · 2017
    Review
  19. Role of CysACS omega · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shiyu ChenInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.ORCID 000000016578561X
Ranganath GopalakrishnanInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Tifany SchaerHiQScreen, CH-1022 Vésenaz, Geneva, Switzerland.
Fabrice MargerHiQScreen, CH-1022 Vésenaz, Geneva, Switzerland.
Ruud HoviusInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.ORCID 0000000192586587
Daniel BertrandHiQScreen, CH-1022 Vésenaz, Geneva, Switzerland.
Florence PojerProtein Crystallography Core Facility, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Christian HeinisInstitute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
École Polytechnique Fédérale de Lausanne · CHHiQScreen (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The disulfide bonds that form between two cysteine residues are important in defining and rigidifying the structures of proteins and peptides. In polypeptides containing multiple cysteine residues, disulfide isomerization can lead to multiple products with different biological activities. Here, we describe the development of a dithiol amino acid (Dtaa) that can form two disulfide bridges at a single amino acid site. Application of Dtaas to a serine protease inhibitor and a nicotinic acetylcholine receptor inhibitor that contain disulfide constraints enhanced their inhibitory activities 40- and 7.6-fold, respectively. X-ray crystallographic and NMR structure analysis show that the peptide ligands containing Dtaas have retained their native tertiary structures. We furthermore show that replacement of two cysteines by Dtaas can avoid the formation of disulfide bond isomers. With these properties, Dtaas are likely to have broad application in the rational design or directed evolution of peptides and proteins with high activity and stability.

Indexed as

Amino AcidsBinding SitesCatalytic DomainConotoxinsCrystallography, X-RayDisulfidesIsomerismLigandsMolecular Dynamics SimulationNicotinic AntagonistsPeptidesProtein BindingSerine Proteinase InhibitorsUrokinase-Type Plasminogen ActivatorAmino AcidsConotoxinsDisulfidesLigandsNicotinic AntagonistsPeptidesSerine Proteinase InhibitorsUrokinase-Type Plasminogen Activator

Identifiers

PMID25343607
OpenAlexW2041783957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.